Obalon

allurion

MedTech

Allurion bumps up series C to $27M as it revs up for U.S. trial

Allurion Technologies has raised $27 million in series C funding for its swallowable, procedureless, weight-loss balloon.

Amirah Al Idrus Jul 11, 2017 9:30am

Obalon balloon

Obalon launches $75M IPO for ingestible weight loss balloon

Oct 6, 2016 4:25pm

Obalon

Obalon aims for $75M IPO to back swallowable obesity device launch

Sep 9, 2016 10:58am